Scrip100: the Indian power house that leaves big pharma standing
This article was originally published in Scrip
Executive Summary
Organic growth is important, but as Sun Pharmaceutical has consistently shown, maintaining operating margins may hold the key to the continued rise of Indian pharmaceutical companies.